MREO
Mereo BioPharma Group Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.29
−4.08%Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -1.02x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.89x
Liquidity & coverage
- Current ratio
- 5.88x
- Quick ratio
- 5.88x
- Cash ratio
- 5.31x
- Interest coverage
- -393.73x
- EBITDA / interest
- -377.17x
- Working capital
- $27.7M
Cash & dividend
- FCF / debt
- -24.61x
- Cash flow / debt
- -24.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026